← FDA Drug Approvals (Drugs@FDA)

DAPSONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TARO · Approved 2019-03-01

Drug application

FDA Application #

ANDA209430

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPSONE

Generic name

DAPSONE

Active ingredients

DAPSONE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

TARO

Manufacturer

Sun Pharmaceutical Industries, Inc.

First approval

2019-03-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown